Table 1 Baseline characteristics of patients on VA-ECMO for ACF
Survivor | No- Survivor | p-value | |
|---|---|---|---|
Age | 43.9 ± 16.7 | 45.8 ± 16.8 | 0.638 |
Sex(M:F) | 22/17 | 23/9 | 0.220 |
BMI | 23.1 ± 3.4 | 24.1 ± 3.5 | 0.227 |
Comorbidities, n (%) | |||
Coronary artery disease | 1 (2.6) | 1 (3.1) | > 0.999 |
Hypertension | 5 (12.8) | 8 (25.0) | 0.227 |
Diabetes Mellitus | 3 (7.7) | 7 (21.9) | 0.168 |
Lung disease | 1 (2.6) | 2 (6.3) | 0.585 |
Previous Arrhythmia | 0 (0.00) | 2 (6.3) | 0.200 |
Tumour | 3 (7.7) | 2 (6.3) | > 0.999 |
Autoimmune disease | 3 (7.7) | 0 (0.00) | 0.247 |
Smoking | 10 (25.6) | 11 (34.4) | 0.446 |
Alcohol | 9 (23.1) | 5 (15.6) | 0.553 |
APACHE II | 24.0 [19.0, 31.5] | 34.50 [28.3, 36.0] | 0.002 |
Protopathy | 0.003 | ||
FMC | 24 (61.5) | 7 (21.9) | |
AMI | 10 (25.6) | 12 (37.5) | |
SACM | 2 (5.1) | 3 (9.4) | |
OCCA | 3 (7.7) | 10 (31.3) | |
Reason of ECMO | 0.002 | ||
RSC | 26 (66.7) | 9 (28.1) | |
CA | 13 (33.3) | 23 (71.9) | |
Complications | |||
Bleeding | 3 (7.7) | 16 (50.0) | < 0.001 |
CRBSI | 0 (0.0) | 3 (9.4) | 0.087 |
ECMO support time | 131.0 [116.0, 178.0] | 168.5 [124.3, 219.3] | 0.047 |
tIPPaO2 | 30.0 [17.5, 50.0] | 92.00 [48.8, 148.5] | < 0.001 |
ICU time | 17.0 [15.0, 24.5] | 9.0 [7.0, 13.3] | < 0.001 |
length of stay | 20.0 [17.5, 30.0] | 9.00 [7.0, 13.3] | < 0.001 |
CRRT time | 0.0 [0.0, 5.0] | 6.0 [3.0, 8.3] | 0.001 |
MV time | 7.0 [5.0, 9.0] | 9.00 [7.0, 12.3] | 0.022 |
Platelet | 69.5 [50.3, 93.0] | 31.0 [22.8, 42.3] | < 0.001 |